Australia markets close in 1 hour 18 minutes

Ever Supreme Bio Technology Co., Ltd (6712.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
212.00-2.00 (-0.93%)
As of 11:33AM CST. Market open.
Currency in TWD

Valuation measures4

Market cap (intra-day) 13.52B
Enterprise value 12.38B
Trailing P/E 90.77
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)22.93
Price/book (mrq)8.26
Enterprise value/revenue 20.53
Enterprise value/EBITDA 52.68

Trading information

Stock price history

Beta (5Y monthly) 0.41
52-week change 326.22%
S&P500 52-week change 3-13.21%
52-week high 3277.50
52-week low 3155.00
50-day moving average 3212.08
200-day moving average 3197.54

Share statistics

Avg vol (3-month) 31.86M
Avg vol (10-day) 31.09M
Shares outstanding 568.09M
Implied shares outstanding 6N/A
Float 8N/A
% held by insiders 144.66%
% held by institutions 15.87%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 45
Forward annual dividend yield 42.50%
Trailing annual dividend rate 34.55
Trailing annual dividend yield 32.12%
5-year average dividend yield 4N/A
Payout ratio 4225.23%
Dividend date 3N/A
Ex-dividend date 419 May 2022
Last split factor 21100:1000
Last split date 319 May 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Sept 2022


Profit margin 25.33%
Operating margin (ttm)40.82%

Management effectiveness

Return on assets (ttm)8.18%
Return on equity (ttm)8.78%

Income statement

Revenue (ttm)602.86M
Revenue per share (ttm)8.86
Quarterly revenue growth (yoy)19.40%
Gross profit (ttm)245.48M
EBITDA 269.92M
Net income avi to common (ttm)152.68M
Diluted EPS (ttm)2.33
Quarterly earnings growth (yoy)-83.60%

Balance sheet

Total cash (mrq)1.16B
Total cash per share (mrq)17.1
Total debt (mrq)28.46M
Total debt/equity (mrq)1.71
Current ratio (mrq)9.21
Book value per share (mrq)24.41

Cash flow statement

Operating cash flow (ttm)282.52M
Levered free cash flow (ttm)175.54M